Design, Build, Test, and Learn are the four stages of the artificial intelligence (AI) drug design cycle. Generative AI uses high-throughput protein expression to generate new drug candidates and assess their developability and effectiveness.
The data from these tests improve AI models for subsequent designs. This iterative process enhances the efficiency and inventiveness of drug discovery.
GenScript's cell-free protein synthesis system revolutionizes conventional expression techniques by facilitating effective protein synthesis in vitro. This cutting-edge system drastically cuts down on the time and cost involved with high-throughput expression and is renowned for its speed, efficiency, flexibility, and affordability. It acts as a potent stimulant for model training and early AI-driven drug screening.
Image Credit: GenScript
Cell-free expression workflows
Image Credit: GenScript
Service highlights
Industrial-leading speed
- Results available in five business days
Strict QC
- Complete QC plasmid sequencing
Large capacity
HT BLI bundle
- Every day, 600 samples are bundled by HT BLI
Service specification
Cell-free expression services
Source: GenScript
| Format |
Volume |
Timeline* |
Deliverables |
| VHH - His |
1 ml (Target yield 10-200 μg) |
5 Business Days |
Target Protein, CoA Report
(A280, SDS-PAGE) |
| 5 ml (Target yield 100-1000 μg) |
5 Business Days |
| Other format |
1/5 mL |
Pre-evaluation |
*Sample# > 200 in one batch, may take extra time for production.
Cell-free and BLI HT binding services
Source: GenScript
| Format |
Volume |
Timeline* |
BLI Binding Report |
Deliverable |
| VHH-His |
1 mL Supernatant |
6 Business Days |
- Negative
- Ambiguous
- Positive
|
BLI Binding Report
|
|
1. This service is only applicable to VHH-His, other formats need pre-evaluation.
2. Sample size > 96 may take extra time for BLI testing.